BH3 interacting domain death agonist
BH3 Interacting Domain Death Agonist (BID) is a pro-apoptotic member of the Bcl-2 protein family, which plays a central role in the regulation of programmed cell death or apoptosis. BID is unique among the Bcl-2 family members due to its dual role as a sensor and effector of apoptosis. It acts as a bridge between the death receptor-mediated and the mitochondrial apoptosis pathways.
Function[edit | edit source]
BID is synthesized as an inactive precursor that is activated upon cleavage by Caspase 8, a cysteine protease that is activated as part of the extrinsic apoptosis pathway. The cleavage of BID results in a truncated form, tBID, which translocates to the mitochondria where it induces the release of cytochrome c and other pro-apoptotic factors. This release initiates the intrinsic apoptosis pathway by activating downstream caspases, leading to cell death.
Structure[edit | edit source]
The structure of BID includes a BH3 domain, which is critical for its interaction with other Bcl-2 family proteins. The BH3 domain enables BID to bind to and neutralize pro-survival Bcl-2 proteins, thereby promoting apoptosis. BID's ability to interact with both pro-apoptotic and anti-apoptotic members of the Bcl-2 family through its BH3 domain underscores its role as a key regulator of apoptosis.
Clinical Significance[edit | edit source]
Alterations in BID function or expression have been implicated in a variety of diseases, including cancer, where its dysregulation can contribute to the resistance of cancer cells to apoptosis. Understanding the role of BID in apoptosis has led to the development of therapeutic strategies aimed at modulating its activity to promote the death of cancer cells.
Research[edit | edit source]
Research on BID has focused on elucidating its mechanism of action, its role in disease, and its potential as a therapeutic target. Studies have explored the use of BH3 mimetics, small molecules that can mimic the action of BID and other pro-apoptotic proteins, as a strategy to induce apoptosis in cancer cells.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD